» Articles » PMID: 39328246

Endocan, a Novel Glycoprotein with Multiple Biological Activities, May Play Important Roles in Neurological Diseases

Overview
Specialty Geriatrics
Date 2024 Sep 27
PMID 39328246
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cell specific-1 (), also known as endocan, is a soluble dermatan sulfate proteoglycan that is mainly secreted by endothelial cells. Endocan is associated with tumorigenesis and cancer progression and is also related to cardiovascular disorders, autoimmune diseases, and sepsis. The phenylalanine-rich region and linear polysaccharide of endocan are necessary for the protein to exert its biological functions. Elevated plasma endocan levels reflect endothelial activation and dysfunction. In addition, endocan participates in complex inflammatory responses and proliferative processes. Here, we reviewed current research on endocan, elaborated the protein's structure and biological functions, and speculated on its possible clinical value in nervous system diseases. We conclude that endocan may be a glycoprotein that plays an important role in neurological disorders.

References
1.
Benini R, Roth R, Khoja Z, Avoli M, Wintermark P . Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy?. Int J Dev Neurosci. 2016; 49:31-6. PMC: 4878886. DOI: 10.1016/j.ijdevneu.2016.01.001. View

2.
Lin J, Hsu B, Wang C, Tsai J . Endocan as a Potential Marker for Predicting All-Cause Mortality in Hemodialysis Patients. J Clin Med. 2023; 12(23). PMC: 10706971. DOI: 10.3390/jcm12237427. View

3.
De Freitas Caires N, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D . Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. J Pharm Biomed Anal. 2013; 78-79:45-51. DOI: 10.1016/j.jpba.2013.01.035. View

4.
Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C . Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2005; 1765(1):25-37. DOI: 10.1016/j.bbcan.2005.08.004. View

5.
Reyes N, Benedetti I, Bettin A, Rebollo J, Geliebter J . The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue. Cancer Biomark. 2015; 16(1):191-202. DOI: 10.3233/CBM-150555. View